nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifampicin—CYP4A11—Cisplatin—urinary bladder cancer	0.0703	0.0873	CbGbCtD
Rifampicin—ABCC5—Fluorouracil—urinary bladder cancer	0.0632	0.0785	CbGbCtD
Rifampicin—ABCC5—Cisplatin—urinary bladder cancer	0.0537	0.0667	CbGbCtD
Rifampicin—ABCC3—Fluorouracil—urinary bladder cancer	0.0398	0.0494	CbGbCtD
Rifampicin—CYP2B6—Thiotepa—urinary bladder cancer	0.0354	0.0439	CbGbCtD
Rifampicin—ABCC3—Cisplatin—urinary bladder cancer	0.0338	0.0419	CbGbCtD
Rifampicin—ABCC3—Etoposide—urinary bladder cancer	0.0332	0.0412	CbGbCtD
Rifampicin—SLC22A7—Fluorouracil—urinary bladder cancer	0.0311	0.0386	CbGbCtD
Rifampicin—ABCC1—Epirubicin—urinary bladder cancer	0.0261	0.0325	CbGbCtD
Rifampicin—UGT1A1—Etoposide—urinary bladder cancer	0.0248	0.0308	CbGbCtD
Rifampicin—ABCB1—Mitomycin—urinary bladder cancer	0.0239	0.0297	CbGbCtD
Rifampicin—ABCC3—Doxorubicin—urinary bladder cancer	0.0226	0.0281	CbGbCtD
Rifampicin—ABCC3—Methotrexate—urinary bladder cancer	0.0219	0.0272	CbGbCtD
Rifampicin—ABCC1—Etoposide—urinary bladder cancer	0.0204	0.0253	CbGbCtD
Rifampicin—ABCB11—Doxorubicin—urinary bladder cancer	0.0196	0.0243	CbGbCtD
Rifampicin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0195	0.0242	CbGbCtD
Rifampicin—ABCC2—Carboplatin—urinary bladder cancer	0.018	0.0223	CbGbCtD
Rifampicin—CYP2A6—Fluorouracil—urinary bladder cancer	0.0176	0.0219	CbGbCtD
Rifampicin—SLC22A7—Methotrexate—urinary bladder cancer	0.0171	0.0213	CbGbCtD
Rifampicin—ABCC2—Cisplatin—urinary bladder cancer	0.0153	0.0191	CbGbCtD
Rifampicin—ABCC2—Etoposide—urinary bladder cancer	0.0151	0.0187	CbGbCtD
Rifampicin—ABCC1—Doxorubicin—urinary bladder cancer	0.0139	0.0173	CbGbCtD
Rifampicin—ABCC1—Methotrexate—urinary bladder cancer	0.0135	0.0167	CbGbCtD
Rifampicin—SLCO1A2—Methotrexate—urinary bladder cancer	0.012	0.0149	CbGbCtD
Rifampicin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0113	0.0141	CbGbCtD
Rifampicin—CYP3A4—Thiotepa—urinary bladder cancer	0.0109	0.0135	CbGbCtD
Rifampicin—ABCC2—Doxorubicin—urinary bladder cancer	0.0103	0.0128	CbGbCtD
Rifampicin—ABCC2—Methotrexate—urinary bladder cancer	0.00996	0.0124	CbGbCtD
Rifampicin—CYP2B6—Cisplatin—urinary bladder cancer	0.00976	0.0121	CbGbCtD
Rifampicin—CYP2E1—Etoposide—urinary bladder cancer	0.00972	0.0121	CbGbCtD
Rifampicin—CYP2C8—Fluorouracil—urinary bladder cancer	0.0087	0.0108	CbGbCtD
Rifampicin—CYP3A5—Etoposide—urinary bladder cancer	0.00755	0.00938	CbGbCtD
Rifampicin—CYP2C8—Etoposide—urinary bladder cancer	0.00726	0.00902	CbGbCtD
Rifampicin—ABCB1—Gemcitabine—urinary bladder cancer	0.00689	0.00855	CbGbCtD
Rifampicin—CYP1A2—Fluorouracil—urinary bladder cancer	0.00674	0.00836	CbGbCtD
Rifampicin—CYP2B6—Doxorubicin—urinary bladder cancer	0.00654	0.00812	CbGbCtD
Rifampicin—CYP2C9—Fluorouracil—urinary bladder cancer	0.00607	0.00753	CbGbCtD
Rifampicin—CYP1A2—Etoposide—urinary bladder cancer	0.00562	0.00698	CbGbCtD
Rifampicin—CYP2C9—Cisplatin—urinary bladder cancer	0.00515	0.0064	CbGbCtD
Rifampicin—ABCB1—Cisplatin—urinary bladder cancer	0.005	0.00621	CbGbCtD
Rifampicin—ABCB1—Etoposide—urinary bladder cancer	0.00492	0.0061	CbGbCtD
Rifampicin—UGT1A1—urine—urinary bladder cancer	0.00464	0.0845	CbGeAlD
Rifampicin—ABCB1—Doxorubicin—urinary bladder cancer	0.00335	0.00416	CbGbCtD
Rifampicin—ABCB1—Methotrexate—urinary bladder cancer	0.00325	0.00403	CbGbCtD
Rifampicin—CYP3A4—Etoposide—urinary bladder cancer	0.00294	0.00366	CbGbCtD
Rifampicin—CYP2C19—urine—urinary bladder cancer	0.00252	0.0458	CbGeAlD
Rifampicin—CYP4A11—renal system—urinary bladder cancer	0.00219	0.0398	CbGeAlD
Rifampicin—CYP1A2—urine—urinary bladder cancer	0.00206	0.0374	CbGeAlD
Rifampicin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00201	0.00249	CbGbCtD
Rifampicin—CYP2C9—urine—urinary bladder cancer	0.00195	0.0355	CbGeAlD
Rifampicin—CYP2E1—urine—urinary bladder cancer	0.00185	0.0336	CbGeAlD
Rifampicin—UGT1A1—prostate gland—urinary bladder cancer	0.00167	0.0303	CbGeAlD
Rifampicin—CYP4A11—vagina—urinary bladder cancer	0.00158	0.0288	CbGeAlD
Rifampicin—ABCC5—prostate gland—urinary bladder cancer	0.00157	0.0285	CbGeAlD
Rifampicin—CYP3A4—urine—urinary bladder cancer	0.00149	0.0271	CbGeAlD
Rifampicin—CYP2A6—prostate gland—urinary bladder cancer	0.0014	0.0256	CbGeAlD
Rifampicin—ABCC3—prostate gland—urinary bladder cancer	0.00132	0.0239	CbGeAlD
Rifampicin—SLC22A7—renal system—urinary bladder cancer	0.00127	0.0231	CbGeAlD
Rifampicin—SLCO2B1—prostate gland—urinary bladder cancer	0.00123	0.0223	CbGeAlD
Rifampicin—CYP2A6—seminal vesicle—urinary bladder cancer	0.00119	0.0216	CbGeAlD
Rifampicin—SLCO1B3—vagina—urinary bladder cancer	0.00118	0.0215	CbGeAlD
Rifampicin—UGT1A1—renal system—urinary bladder cancer	0.00114	0.0207	CbGeAlD
Rifampicin—ABCC2—prostate gland—urinary bladder cancer	0.00105	0.0191	CbGeAlD
Rifampicin—SLCO1B1—renal system—urinary bladder cancer	0.000945	0.0172	CbGeAlD
Rifampicin—ABCC1—prostate gland—urinary bladder cancer	0.000926	0.0169	CbGeAlD
Rifampicin—ABCC3—renal system—urinary bladder cancer	0.000897	0.0163	CbGeAlD
Rifampicin—SLCO2B1—renal system—urinary bladder cancer	0.000836	0.0152	CbGeAlD
Rifampicin—ABCC1—seminal vesicle—urinary bladder cancer	0.000783	0.0143	CbGeAlD
Rifampicin—ABCC5—vagina—urinary bladder cancer	0.000774	0.0141	CbGeAlD
Rifampicin—SLCO1A2—renal system—urinary bladder cancer	0.000769	0.014	CbGeAlD
Rifampicin—SLCO1B1—female reproductive system—urinary bladder cancer	0.000757	0.0138	CbGeAlD
Rifampicin—ABCC3—female reproductive system—urinary bladder cancer	0.000718	0.0131	CbGeAlD
Rifampicin—ABCC2—renal system—urinary bladder cancer	0.000717	0.013	CbGeAlD
Rifampicin—CYP3A5—prostate gland—urinary bladder cancer	0.000712	0.013	CbGeAlD
Rifampicin—CYP2A6—vagina—urinary bladder cancer	0.000694	0.0126	CbGeAlD
Rifampicin—SLCO2B1—female reproductive system—urinary bladder cancer	0.000669	0.0122	CbGeAlD
Rifampicin—CYP2E1—prostate gland—urinary bladder cancer	0.000664	0.0121	CbGeAlD
Rifampicin—ABCC1—urethra—urinary bladder cancer	0.00062	0.0113	CbGeAlD
Rifampicin—ABCC2—female reproductive system—urinary bladder cancer	0.000574	0.0104	CbGeAlD
Rifampicin—CYP2E1—seminal vesicle—urinary bladder cancer	0.000561	0.0102	CbGeAlD
Rifampicin—CYP2C8—renal system—urinary bladder cancer	0.000537	0.00978	CbGeAlD
Rifampicin—CYP1A2—renal system—urinary bladder cancer	0.000503	0.00915	CbGeAlD
Rifampicin—ABCC5—lymph node—urinary bladder cancer	0.0005	0.0091	CbGeAlD
Rifampicin—CYP3A5—renal system—urinary bladder cancer	0.000485	0.00883	CbGeAlD
Rifampicin—CYP2B6—renal system—urinary bladder cancer	0.000482	0.00877	CbGeAlD
Rifampicin—ABCC1—vagina—urinary bladder cancer	0.000457	0.00832	CbGeAlD
Rifampicin—CYP2E1—renal system—urinary bladder cancer	0.000452	0.00823	CbGeAlD
Rifampicin—CYP2C19—vagina—urinary bladder cancer	0.000446	0.00812	CbGeAlD
Rifampicin—CYP2E1—urethra—urinary bladder cancer	0.000444	0.00809	CbGeAlD
Rifampicin—CYP2C8—female reproductive system—urinary bladder cancer	0.00043	0.00783	CbGeAlD
Rifampicin—ABCC3—lymph node—urinary bladder cancer	0.00042	0.00765	CbGeAlD
Rifampicin—SLCO2B1—lymph node—urinary bladder cancer	0.000392	0.00713	CbGeAlD
Rifampicin—CYP2C8—vagina—urinary bladder cancer	0.000389	0.00708	CbGeAlD
Rifampicin—CYP2B6—female reproductive system—urinary bladder cancer	0.000386	0.00703	CbGeAlD
Rifampicin—CYP2C9—female reproductive system—urinary bladder cancer	0.000382	0.00696	CbGeAlD
Rifampicin—ABCB1—prostate gland—urinary bladder cancer	0.000378	0.00688	CbGeAlD
Rifampicin—CYP3A4—renal system—urinary bladder cancer	0.000364	0.00662	CbGeAlD
Rifampicin—CYP2E1—female reproductive system—urinary bladder cancer	0.000362	0.00659	CbGeAlD
Rifampicin—CYP3A5—vagina—urinary bladder cancer	0.000351	0.00639	CbGeAlD
Rifampicin—CYP2B6—vagina—urinary bladder cancer	0.000349	0.00635	CbGeAlD
Rifampicin—ABCC2—lymph node—urinary bladder cancer	0.000336	0.00611	CbGeAlD
Rifampicin—ABCB1—seminal vesicle—urinary bladder cancer	0.00032	0.00582	CbGeAlD
Rifampicin—ABCC1—lymph node—urinary bladder cancer	0.000296	0.00538	CbGeAlD
Rifampicin—CYP3A4—female reproductive system—urinary bladder cancer	0.000292	0.0053	CbGeAlD
Rifampicin—ABCB1—epithelium—urinary bladder cancer	0.000278	0.00506	CbGeAlD
Rifampicin—ABCB1—renal system—urinary bladder cancer	0.000258	0.00469	CbGeAlD
Rifampicin—ABCB1—urethra—urinary bladder cancer	0.000253	0.00461	CbGeAlD
Rifampicin—ABCB1—female reproductive system—urinary bladder cancer	0.000206	0.00376	CbGeAlD
Rifampicin—ABCB1—vagina—urinary bladder cancer	0.000187	0.0034	CbGeAlD
Rifampicin—ABCB1—lymph node—urinary bladder cancer	0.000121	0.0022	CbGeAlD
Rifampicin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	9.34e-06	6.69e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	9.23e-06	6.61e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	9.17e-06	6.57e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	9.15e-06	6.56e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	9.07e-06	6.5e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	9.07e-06	6.5e-05	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—MTHFR—urinary bladder cancer	9.07e-06	6.5e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	9.06e-06	6.49e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.02e-06	6.46e-05	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—CREBBP—urinary bladder cancer	9.02e-06	6.46e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	8.95e-06	6.41e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	8.95e-06	6.41e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	8.93e-06	6.39e-05	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	8.81e-06	6.31e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	8.8e-06	6.3e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.75e-06	6.27e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	8.74e-06	6.26e-05	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—PTEN—urinary bladder cancer	8.73e-06	6.26e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	8.73e-06	6.25e-05	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—PTGS2—urinary bladder cancer	8.68e-06	6.22e-05	CbGpPWpGaD
Rifampicin—ABCC5—Disease—MYC—urinary bladder cancer	8.67e-06	6.21e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.66e-06	6.21e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	8.64e-06	6.19e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	8.64e-06	6.19e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	8.62e-06	6.17e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	8.57e-06	6.14e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—RRM2—urinary bladder cancer	8.53e-06	6.11e-05	CbGpPWpGaD
Rifampicin—ABCC5—Disease—EGFR—urinary bladder cancer	8.48e-06	6.07e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—NQO1—urinary bladder cancer	8.46e-06	6.06e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	8.44e-06	6.05e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—CREBBP—urinary bladder cancer	8.44e-06	6.04e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	8.42e-06	6.03e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	8.42e-06	6.03e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.38e-06	6e-05	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—EP300—urinary bladder cancer	8.33e-06	5.97e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—TYMS—urinary bladder cancer	8.3e-06	5.95e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	8.2e-06	5.88e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	8.2e-06	5.88e-05	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	8.18e-06	5.86e-05	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	8.17e-06	5.85e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	8.1e-06	5.8e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	8.1e-06	5.8e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.05e-06	5.77e-05	CbGpPWpGaD
Rifampicin—ABCC5—Disease—KRAS—urinary bladder cancer	8.01e-06	5.74e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	7.97e-06	5.71e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	7.91e-06	5.67e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—ENO2—urinary bladder cancer	7.9e-06	5.66e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	7.9e-06	5.66e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	7.89e-06	5.65e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—GPX1—urinary bladder cancer	7.86e-06	5.63e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	7.85e-06	5.62e-05	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	7.85e-06	5.62e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.73e-06	5.54e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	7.71e-06	5.53e-05	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—PTGS2—urinary bladder cancer	7.7e-06	5.52e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	7.66e-06	5.49e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—RHOA—urinary bladder cancer	7.63e-06	5.47e-05	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—PPARG—urinary bladder cancer	7.63e-06	5.46e-05	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—PTEN—urinary bladder cancer	7.57e-06	5.42e-05	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—PTGS2—urinary bladder cancer	7.38e-06	5.29e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	7.38e-06	5.29e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	7.38e-06	5.29e-05	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—PPARG—urinary bladder cancer	7.35e-06	5.27e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.34e-06	5.26e-05	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	7.33e-06	5.25e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	7.31e-06	5.24e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	7.25e-06	5.19e-05	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—EP300—urinary bladder cancer	7.22e-06	5.17e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	7.2e-06	5.16e-05	CbGpPWpGaD
Rifampicin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.18e-06	5.14e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	7.16e-06	5.13e-05	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	7.14e-06	5.11e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.09e-06	5.08e-05	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—CREBBP—urinary bladder cancer	7.07e-06	5.06e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—ERBB2—urinary bladder cancer	7.07e-06	5.06e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	7.06e-06	5.05e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.05e-06	5.05e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	7.04e-06	5.04e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	6.99e-06	5.01e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—PTGS2—urinary bladder cancer	6.91e-06	4.95e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	6.81e-06	4.88e-05	CbGpPWpGaD
Rifampicin—ABCC5—Disease—HRAS—urinary bladder cancer	6.81e-06	4.88e-05	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	6.81e-06	4.87e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	6.73e-06	4.82e-05	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—PTEN—urinary bladder cancer	6.72e-06	4.81e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	6.71e-06	4.81e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	6.7e-06	4.8e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	6.62e-06	4.74e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	6.62e-06	4.74e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—TYMS—urinary bladder cancer	6.56e-06	4.7e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	6.55e-06	4.69e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	6.53e-06	4.67e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	6.48e-06	4.64e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	6.48e-06	4.64e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	6.47e-06	4.63e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	6.47e-06	4.63e-05	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—PTEN—urinary bladder cancer	6.44e-06	4.61e-05	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	6.43e-06	4.61e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	6.41e-06	4.59e-05	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—EP300—urinary bladder cancer	6.41e-06	4.59e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—NQO1—urinary bladder cancer	6.37e-06	4.56e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	6.34e-06	4.54e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.33e-06	4.54e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	6.31e-06	4.52e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	6.31e-06	4.52e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.27e-06	4.49e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	6.22e-06	4.46e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—GPX1—urinary bladder cancer	6.21e-06	4.45e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	6.2e-06	4.44e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.19e-06	4.43e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	6.16e-06	4.41e-05	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—EP300—urinary bladder cancer	6.14e-06	4.4e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	6.12e-06	4.38e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	6.1e-06	4.37e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	6.1e-06	4.37e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.09e-06	4.36e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	6.08e-06	4.36e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—CDKN1A—urinary bladder cancer	6.04e-06	4.33e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.03e-06	4.32e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—PTEN—urinary bladder cancer	6.02e-06	4.32e-05	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	6e-06	4.3e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	5.95e-06	4.26e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.9e-06	4.23e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—PPARG—urinary bladder cancer	5.88e-06	4.21e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	5.85e-06	4.19e-05	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—PTGS2—urinary bladder cancer	5.79e-06	4.14e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.77e-06	4.14e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—EP300—urinary bladder cancer	5.75e-06	4.12e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	5.73e-06	4.1e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	5.72e-06	4.1e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	5.67e-06	4.06e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	5.65e-06	4.05e-05	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	5.61e-06	4.02e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	5.6e-06	4.01e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	5.6e-06	4.01e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—SRC—urinary bladder cancer	5.59e-06	4e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.52e-06	3.96e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	5.5e-06	3.94e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	5.44e-06	3.9e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	5.37e-06	3.84e-05	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	5.35e-06	3.83e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	5.31e-06	3.81e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	5.27e-06	3.77e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.27e-06	3.77e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	5.26e-06	3.77e-05	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—PTEN—urinary bladder cancer	5.23e-06	3.75e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	5.09e-06	3.64e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.06e-06	3.62e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	5.05e-06	3.61e-05	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—PTEN—urinary bladder cancer	5.05e-06	3.61e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.04e-06	3.61e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—MYC—urinary bladder cancer	5.01e-06	3.59e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5e-06	3.58e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5e-06	3.58e-05	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—EP300—urinary bladder cancer	4.99e-06	3.57e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.96e-06	3.56e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	4.95e-06	3.55e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—TYMS—urinary bladder cancer	4.94e-06	3.54e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.93e-06	3.53e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—EGFR—urinary bladder cancer	4.9e-06	3.51e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	4.88e-06	3.5e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	4.88e-06	3.5e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.87e-06	3.49e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.87e-06	3.49e-05	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—EP300—urinary bladder cancer	4.81e-06	3.45e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.8e-06	3.44e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	4.79e-06	3.43e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.79e-06	3.43e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	4.74e-06	3.4e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.72e-06	3.38e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.7e-06	3.37e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—GPX1—urinary bladder cancer	4.68e-06	3.35e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—PPARG—urinary bladder cancer	4.65e-06	3.33e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	4.64e-06	3.32e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—KRAS—urinary bladder cancer	4.63e-06	3.31e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	4.63e-06	3.31e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	4.61e-06	3.31e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	4.59e-06	3.29e-05	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	4.57e-06	3.28e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	4.56e-06	3.27e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	4.56e-06	3.27e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	4.56e-06	3.26e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	4.46e-06	3.2e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	4.45e-06	3.19e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.42e-06	3.17e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	4.4e-06	3.15e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.37e-06	3.13e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	4.31e-06	3.09e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.3e-06	3.08e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.29e-06	3.07e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	4.24e-06	3.04e-05	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—EP300—urinary bladder cancer	4.2e-06	3.01e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.1e-06	2.94e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—PTEN—urinary bladder cancer	4.03e-06	2.89e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.03e-06	2.89e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	4.02e-06	2.88e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	3.94e-06	2.82e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—HRAS—urinary bladder cancer	3.93e-06	2.82e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.92e-06	2.81e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	3.9e-06	2.79e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	3.9e-06	2.79e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.86e-06	2.76e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—EP300—urinary bladder cancer	3.85e-06	2.76e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.73e-06	2.67e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	3.73e-06	2.67e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.66e-06	2.62e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	3.66e-06	2.62e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.65e-06	2.61e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.58e-06	2.57e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—PPARG—urinary bladder cancer	3.5e-06	2.51e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	3.44e-06	2.47e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.44e-06	2.47e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	3.36e-06	2.41e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.27e-06	2.34e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.27e-06	2.34e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	3.25e-06	2.33e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—PTEN—urinary bladder cancer	3.19e-06	2.28e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	3.18e-06	2.28e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	3.16e-06	2.26e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.14e-06	2.25e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—EP300—urinary bladder cancer	3.1e-06	2.22e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.04e-06	2.18e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—EP300—urinary bladder cancer	3.04e-06	2.18e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—EP300—urinary bladder cancer	3.03e-06	2.17e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.01e-06	2.15e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.01e-06	2.15e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.88e-06	2.06e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.83e-06	2.03e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.82e-06	2.02e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.79e-06	2e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.76e-06	1.97e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.75e-06	1.97e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.68e-06	1.92e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.66e-06	1.9e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.63e-06	1.88e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.57e-06	1.84e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.46e-06	1.76e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.4e-06	1.72e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.35e-06	1.68e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—EP300—urinary bladder cancer	2.29e-06	1.64e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.24e-06	1.61e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.2e-06	1.57e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.16e-06	1.54e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.14e-06	1.53e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.07e-06	1.48e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.92e-06	1.37e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.83e-06	1.31e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.7e-06	1.21e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.48e-06	1.06e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.41e-06	1.01e-05	CbGpPWpGaD
